Immune checkpoint inhibition (ICI) has revolutionized the field of non-small cell lung cancer (NSCLC); currently,…
pthomsonAugust 25, 2022
Prediction of treatment response has attracted growing attention in cancer research to improve clinical outcomes…
dcorriganAugust 16, 2022
The authors report a new high-affinity aptamer that binds to the transferrin receptor, also called…
dcorriganAugust 12, 2022
Obstructive sleep apnea (OSA) is an important risk factor for multiple diseases (1). 425 million…
dcorriganAugust 12, 2022
In rodent models of type 2 diabetes (T2D), central administration of fibroblast growth factor 1…
dcorriganAugust 5, 2022
Despite recent therapeutic progress, advanced melanoma remains lethal for many patients. The composition of the…
dcorriganAugust 4, 2022
Read the Publication This week we profile a recent publication in Blood Advances from the…
dcorriganJuly 29, 2022
Pancreatic ductal adenocarcinoma (PDAC) typically presents as metastatic disease at diagnosis and remains refractory to…
dcorriganJuly 29, 2022
The authors' work contributes to a growing research body on mucosal tissue regulatory T cells…
dcorriganJuly 21, 2022
